Archived Live Symposium
When: This symposium originally occurred on November 11th - November 13th, 2024
We are pleased to announce that we have opened registration for the fully archival, On-Demand version of the NPS Discovery: 2024 Novel Synthetic Drugs Threat Symposium from November 11th - November 13th, 2024. The event consisted of ten panels of invited experts on all aspects of new and emerging drugs, and the proliferation of new toxic adulterating substances. This hybrid event was offered live at the Science History Institute in Downtown Philadelphia, and virtually in real time.
* All presentations must be attended to receive credit
CFSRE presented a reprise of its 2018 NPS Symposium, with the goal of bringing together international thought leaders and scientists, policy makers, health professionals, public health and public safety stakeholders working in or impacted by Novel Synthetic Drugs Crisis. The program will have a focus on global impacts of NPS. Professionals from across the world will share current knowledge on NPS trends and emerging threats, review of tools and workflows that have developed over recent years and will work together to imagine and anticipate some of the challenges in NPS in the years ahead.
Over the course of the three days, ten panels of invited international experts representing the latest work on novel synthetic drug pharmacology, detection and identification, harm reduction initiatives based on analytical drug checking data, and many other topics.
The goal of the symposium is to encourage information exchange, improve international cooperation and communication on the increasingly important topic of new and emerging drugs, and to share new discoveries, best practices, and insights not what is coming next in the world of new and emerging drug threats.
Sessions:
- Panel 1: International Trends – Main Threats
- Panel 2: Emerging Threats and the Future of NPS
- Panel 3: NPS Trafficking & Surveillance
- Panel 4: NPS Identification Challenges and Resources
- Panel 5: NPS Pharmacological Threat Assessment
- Panel 6: NPS Outbreak Event Testing
- Panel 7: Synthetic Drugs Policy and Legislation
- Panel 8: Public Health Drug Checking Programs and Harm Reduction
- Panel 9: NPS Clinical Intoxication Case Round Table
- Panel 10: NPS Postmortem Intoxication Case Round Table
Confirmed Presenters Include:
- Members of the CFSRE’s NPS Discovery® Team:
- Barry Logan PhD, Alex Krotulski PhD, Joshua DeBord PhD, Mandi Mohr, Sara Walton
- Expert Community on Early Warning and Surveillance Systems, Toxicology, Pharmacology, Pathology, and Clinical Medicine:
- Richard Bade PhD, University of Queensland, Australia
- Michael Baumann PhD, NIDA Designer Drug Research Unit, Baltimore USA
- Thom Browne, Colombo Plan, Colombo, Sri Lanka
- Larry (Dave) Fluty, Assistant Commissioner US Customs and Border Protection, Laboratories and Scientific Services Division, Washington DC
- Donna Iula PhD, Cayman Chemical, Ann Arbor MI, USA
- Wendy Lee, Illicit Drugs Laboratory, HSA, Singapore
- Karen Macdonald, Toronto Drug Checking Service, St Michaels Hospital, Toronto, Canada
- Dr Alex Manini, Director of the Mount Sinai Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND Center)
- Robert Middleberg PhD, Laboratory Director, NMS Labs
- Dr Lewis Nelson, Professor and Chair Department of Emergency Medicine at Rutgers New Jersey Medical School, NJ USA;
- Donna Papsun, NMS Labs Horsham PA
- Jennifer Schumann PhD, EDNA, Monash University, Melbourne, Australia
- Istvan Ujvary PhD, Honorary Associate Professor at Budapest University of Technology & Economics, Budapest, Hungary
- Representatives of the newly created European Union Drugs Agency (EUDA, formerly EMCDDA)
REGISTER FOR THE on-demand COURSE
FULL COURSE SCHEDULE
MANY THANKS TO THIS YEAR'S SPONSORS!
